Insights into the structure-activity relationship of a type III secretion system inhibitor, aurodox.
Kimishima A, Hagimoto D, Honsho M, Watanabe Y, Iwatsuki M, Tsutsumi H, Inahashi Y, Naher K, Sakai K, Kuwae A, Abe A, Asami Y.
Kimishima A, et al. Among authors: kuwae a.
Bioorg Med Chem Lett. 2022 Aug 1;69:128779. doi: 10.1016/j.bmcl.2022.128779. Epub 2022 May 8.
Bioorg Med Chem Lett. 2022.
PMID: 35545199